Michael Ackermann

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Ackermann:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 12,000 $195,720 $16.31 16 Jun 2022 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 7,000 $76,930 $10.99 16 Jun 2022 Direct

Insider Reports Filed by Michael Ackermann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 16 Jun 2022 2 $0 4 Director 01 Jul 2022, 12:31
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:51
TARS Tarsus Pharmaceuticals, Inc. 05 May 2022 1 +$1,350,000 4 Director 09 May 2022, 16:42
TARS Tarsus Pharmaceuticals, Inc. 01 Dec 2021 4 -$143,934 4 Director 03 Dec 2021, 17:56
TARS Tarsus Pharmaceuticals, Inc. 01 Nov 2021 2 -$162,289 4 Director 03 Nov 2021, 19:00
TARS Tarsus Pharmaceuticals, Inc. 12 Oct 2021 2 -$148,000 4 Director 14 Oct 2021, 16:48
TARS Tarsus Pharmaceuticals, Inc. 08 Oct 2021 1 -$5,006 4 Director 12 Oct 2021, 18:47
TARS Tarsus Pharmaceuticals, Inc. 01 Sep 2021 1 -$147,237 4 Director 03 Sep 2021, 18:53
TARS Tarsus Pharmaceuticals, Inc. 11 Aug 2021 1 -$15,619 4 Director 12 Aug 2021, 17:27
TARS Tarsus Pharmaceuticals, Inc. 06 Aug 2021 2 -$95,725 4 Director 10 Aug 2021, 16:55
TARS Tarsus Pharmaceuticals, Inc. 05 Aug 2021 3 -$34,576 4 Director 06 Aug 2021, 16:16
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2021 4 $0 4 Director 17 Jun 2021, 19:19